Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccination for Recurrent Glioblastoma: A Phase II, Single Arm Trial

被引：17
作者：
Bloch, Orin [1 ]
Parsa, Andrew T. [1 ]
机构：
[1] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
NEURO-ONCOLOGY | 2014年 / 16卷 / 05期
关键词：
WHOLE-BRAIN RADIOTHERAPY; RESECTION; SURVIVAL; EXTENT; BEVACIZUMAB; METASTASES; THERAPY;
D O I：
10.1093/neuonc/nou054
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：758 / 759
页数：2
相关论文
共 15 条
  • [1] Impact of extent of resection for recurrent glioblastoma on overall survival Clinical article
    Bloch, Orin
    Han, Seunggu J.
    Cha, Soonmee
    Sun, Matthew Z.
    Aghi, Manish K.
    McDermott, Michael W.
    Berger, Mitchel S.
    Parsa, Andrew T.
    [J]. JOURNAL OF NEUROSURGERY, 2012, 117 (06) : 1032 - 1038
  • [2] Chamberlain C, 2011, NEURO-ONCOLOGY, V13, P132
  • [3] Should Erlotinib Be Coadministered With Whole-Brain Radiotherapy in Patients With Brain Metastases and Non-Small-Cell Lung Cancer?
    Chamberlain, Marc C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3164 - 3165
  • [4] Does Quality of Life Supplant Survival in Patients With Brain Metastasis?
    Chamberlain, Marc C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (20) : 2635 - 2635
  • [5] Are Prognostic Factors for Leptomeningeal Metastases Defined Sufficiently to Permit Tailored Treatment?
    Chamberlain, Marc C.
    Goulart, Bernardo H. L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (07) : E66 - E67
  • [6] Does RTOG 9802 Change Practice With Respect to Newly Diagnosed Low-Grade Glioma?
    Chamberlain, Marc C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (05) : 652 - 653
  • [7] Is Graded Prognostic Assessment an Improvement Compared With Radiation Therapy Oncology Group's Recursive Partitioning Analysis Classification for Brain Metastases?
    Chamberlain, Marc C.
    Silbergeld, Daniel L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3315 - 3316
  • [8] Is There a Role for Whole Brain Radiotherapy in the Treatment of Leptomeningeal Metastases?
    Chamberlain, Marc C.
    Eaton, Keith
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : 1204 - 1204
  • [9] Surgery, a prognostic marker for progression-free survival?
    Chamberlain, Marc C.
    Silbergeld, Daniel L.
    [J]. NEURO-ONCOLOGY, 2012, 14 (04) : 390 - 391
  • [10] Treatment of Glioblastoma with Bevacizumab Has a New Standard Therapy been Defined?
    Chamberlain, Marc C.
    [J]. CNS DRUGS, 2011, 25 (10) : 815 - 818
12